C22H18FN7O
415.4 g/mol
APIDanger
Idelalisib
CAS870281-82-6
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Idelalisib is a pharmaceutical compound used as an active pharmaceutical ingredient. It is a phosphoinositide 3-kinase inhibitor that blocks the delta isoform of the enzyme, with a structure characterized by multiple aromatic rings and an amine group.
pharmaceutical manufacturing intermediateresearch compound for kinase inhibition studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 870281-82-6
Related Compounds
ReferenceSame Category
Leptomycin A
CAS87081-36-5
pharmaceutical raw material
ReferenceSame Category
Evocalcet
CAS870964-67-3
pharmaceutical raw material
ReferenceSame Category
Raltegravir potassium
CAS871038-72-1
pharmaceutical raw material
ReferenceSame Category
Trametinib
CAS871700-17-3
pharmaceutical raw material
Safety Reference
Danger
H360May damage fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
H361Suspected of damaging fertility or the unborn child
Identifiers
IUPAC Name
5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one
InChIKey
IFSDAJWBUCMOAH-HNNXBMFYSA-N
SMILES
CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
Synonyms (33)
- 40L
- A-1138
- CAL-101
- EX-A330
- Idelalisib (JAN/USAN/INN)
- CAL-101 (GS-1101)
- CAL-101 (Idelalisib)
- CAL-101 (Idelalisib, GS-1101)
- CAL-101/CAL101
- GS 1101
- GS-1101; Idelalisib; CAL-101
- GS-11CAL-101
- Idealisib
- Idelalisib
- Idelalisib (CAL-101)
- Idelalisib (CAL-101,GS-1101)
- SDCCGSBI-0654408.P001
- Zydelig
- Zydelig (TN)
- idelalisibum